Horizon Signs Three Diagnostic Agreements Worth an Initial $3.3 Million

News   Nov 26, 2015

 
Horizon Signs Three Diagnostic Agreements Worth an Initial $3.3 Million
 
 
 

RELATED ARTICLES

A New, Streamlined Approach to Diagnosing and Treating Bowel Cancer

News

Researchers at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have discovered a faster, more cost-effective way to determine which DNA mutations cause human bowel cancer.

READ MORE

Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Texas

News

First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.

READ MORE

Organoids Created from Patients’ Bladder Cancers Could Guide Treatment

News

Columbia University Irving Medical Center (CUIMC) and NewYork-Presbyterian researchers have created patient-specific bladder cancer organoids that mimic many of the characteristics of actual tumors.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE